Ad
Monday, 19 June 2017
Israel's Gamida Cell raises $40 million for bone marrow trial
TEL AVIV (Reuters) - Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment